Altimmune (ALT) Net Margin (2010 - 2025)
Altimmune's (ALT) quarterly Net Margin came in at 291750.0% in Q4 2025, up 75535000.0% year-on-year from N/an in Q4 2024, and up 176.72% on a QoQ basis from 380280.0% in Q3 2025.
Altimmune (ALT) Net Margin (2010 - 2025) Analysis & Trends
Altimmune (ALT) has 16 years of Net Margin data on file, last reported at 291750.0% in Q4 2025.
- On a quarterly basis, Net Margin rose 75535000.0% year-over-year to 291750.0% in Q4 2025; TTM through Dec 2025 was 36878.05%, a 51217305.0% increase from a year earlier, with the FY2025 full-year figure at 36878.05%, up 41236305.0% from the prior year.
- Net Margin for Q4 2025 stood at 291750.0%, up from 380280.0% in the prior quarter.
- Over the last five years, Net Margin for ALT reached as high as 291750.0% in Q4 2025 and fell as low as 1175800.0% in Q3 2022.
- Historically, Net Margin has averaged 243006.47% across 5 years, with a median of 173898.81% in 2022.
- Across the five-year window, Net Margin plunged 115459114 bps in 2022 and jumped 117008978 bps in 2023, its largest moves.
- Year by year, Net Margin stood at 164.24% in 2021, then slumped by 22485 bps to 37092.31% in 2022, then tumbled by 131 bps to 85516.22% in 2023, then tumbled by 442 bps to 463600.0% in 2024, then soared by 163 bps to 291750.0% in 2025.
- Per Business Quant data, the three most recent Net Margin figures were 291750.0% in Q4 2025, 380280.0% in Q3 2025, and 442920.0% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 291,750.00% |
| Sep 30, 2025 | -380,280.00% |
| Jun 30, 2025 | -442,920.00% |
| Mar 31, 2025 | -391,500.00% |
| Dec 31, 2024 | -463,600.00% |
| Sep 30, 2024 | -456,900.00% |
| Jun 30, 2024 | -492,800.00% |
| Mar 31, 2024 | -487,880.00% |
| Dec 31, 2023 | -85,516.22% |
| Sep 30, 2023 | -5,710.22% |
| Jun 30, 2023 | -281,633.33% |
| Mar 31, 2023 | -96,147.62% |
| Dec 31, 2022 | -37,092.31% |
| Sep 30, 2022 | -1,175,800.00% |
| Jun 30, 2022 | -251,650.00% |
| Mar 31, 2022 | -61,181.25% |
| Dec 31, 2021 | -164.24% |
| Sep 30, 2021 | -21,208.86% |
| Jun 30, 2021 | -18,121.68% |
| Mar 31, 2021 | -1,773.76% |